KLOW 80mg

KLOW 80mg Research Blend: Overview

KLOW 80mg is a proprietary multi-peptide research formulation engineered for advanced laboratory investigation of combinatorial tissue repair, extracellular matrix remodeling, and anti-inflammatory pathways. Each vial contains 10mg KPV (Lys-Pro-Val), 10mg BPC-157 (Body Protection Compound-157), 10mg TB-500 (Thymosin Beta-4 fragment), and 50mg GHK-Cu (Copper Tripeptide-1). This four-component blend is designed to enable researchers to study the synergistic interactions between these structurally and mechanistically distinct peptides within a single experimental framework.

KLOW Peptide Composition

KPV (Lys-Pro-Val, 10mg) is the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH). Preclinical studies have demonstrated its potent anti-inflammatory activity through inhibition of NF-κB translocation and suppression of pro-inflammatory cytokine production, including TNF-α and IL-1β. KPV has been investigated for its ability to modulate inflammatory responses across epithelial and mucosal barrier tissues without the melanogenic effects associated with full-length α-MSH.

BPC-157 (10mg) is a stable pentadecapeptide derived from a protective protein found in human gastric juice. Extensive preclinical research has characterized BPC-157’s angiogenic properties via upregulation of vascular endothelial growth factor (VEGF) receptor 2 expression and its ability to promote fibroblast migration and collagen deposition. Studies have investigated BPC-157’s effects on tendon-to-bone healing, gastrointestinal mucosal integrity, and central nervous system recovery following experimental injury models.

TB-500 (10mg) is a synthetic fragment of Thymosin Beta-4, a naturally occurring 43-amino-acid peptide involved in actin sequestration and cellular motility. Preclinical research has established TB-500’s role in promoting endothelial cell differentiation, angiogenesis, and directed cell migration through actin cytoskeleton regulation. TB-500 has been studied extensively in wound healing models, cardiac repair following ischemic injury, and hair follicle cycling regulation.

GHK-Cu (Copper Tripeptide-1, 50mg) is a naturally occurring copper-peptide complex with a high affinity for copper(II) ions. GHK-Cu’s biological activity is concentration-dependent, and research has demonstrated that copper-bound GHK-Cu modulates the expression of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs), promoting a net shift toward extracellular matrix remodeling and collagen synthesis. Preclinical studies have characterized GHK-Cu’s effects on fibroblast proliferation, glycosaminoglycan synthesis, and the activation of wound-healing gene pathways including TGF-β and collagen types I, II, and IV. The 50mg allocation reflects GHK-Cu’s role as the primary matrix-remodeling driver in this research formulation.

KLOW Mechanism of Action: Research Framework

The KLOW Blend combines four peptides operating through complementary but mechanistically distinct pathways, enabling researchers to investigate multi-target tissue repair cascades in a single experimental preparation. KPV provides anti-inflammatory modulation at the NF-κB level, reducing the pro-inflammatory milieu that can impair tissue regeneration. BPC-157 contributes angiogenic signaling and fibroblast recruitment through VEGF and FAK-paxillin pathway activation. TB-500 supports cellular migration and cytoskeletal reorganization through actin-binding properties. GHK-Cu, as the predominant component at 50mg, drives extracellular matrix remodeling through coordinated MMP/TIMP regulation and collagen gene activation. The convergence of these pathways creates a multi-modal research tool for studying integrated tissue repair, inflammation resolution, and matrix regeneration.

KLOW Preparation and Handling

KLOW 80mg is supplied as a lyophilized powder in a multi-dose vial. Researchers should reconstitute with an appropriate volume of bacteriostatic water or sterile diluent according to their experimental protocol. GHK-Cu-containing solutions exhibit a characteristic blue coloration due to the copper-peptide complex. Reconstituted solutions should be stored at 2-8°C and protected from light. Purity is 99%+ by HPLC with mass spectrometry confirmation; where available, Certificates of Analysis are published on our COA page. For research use only. Not for human consumption.

KLOW 80mg FAQ

What is KLOW 80mg?

KLOW 80mg is a research blend of four peptides in one lyophilized vial: 10 mg KPV, 10 mg BPC-157, 10 mg TB-500 and 50 mg GHK-Cu. It is designed for laboratory studies that examine inflammatory signaling, cell migration and extracellular-matrix remodeling within a single experimental system.

Why use a blend instead of individual peptides?

A blend gives a fixed ratio of components that is the same from vial to vial. Results reflect the combination, so many study designs also include control arms run with the single peptides, which are available separately as KPV 10mg, BPC-157 10mg, TB-500 10mg and GHK-Cu 50mg.

Is KLOW from BioSim Peptides third-party tested?

Yes. KLOW 80mg is supplied at 99%+ purity and is third-party tested by an independent laboratory. Its certificate of analysis is published on our COA page rather than shipped in the package, so you can review it before you order.

How fast does BioSim Peptides ship?

Orders ship in 2 business days. Delivery time depends on your location and the shipping method selected at checkout.

Is KLOW 80mg from BioSim Peptides intended for human use?

No. KLOW 80mg is supplied for laboratory research use only and is not for human consumption. It is not a drug, dietary supplement, cosmetic, or food, and is not intended for diagnosis, treatment, cure, or prevention of any disease in humans or animals.

Related Research

• Best Peptides for Tissue Repair Research
• Comparing Research Peptides: BPC-157 vs TB-500 vs GHK-Cu – Mechanisms and Applications

View the certificate of analysis on our COA page.